logo
Editorial Comment: Reduction in Calcineurin Inhibitor Exposure and Maintenance of Effective Immunosuppression: Clinical Experience with Everolimus (Certican)
Guest Editor’s Introduction
Introducing Everolimus (Certican) in Organ Transplantation: An Overview of Preclinical and Early Clinical Developments
Concentration-Controlled Everolimus (Certican): Combination with Reduced Dose Calcineurin Inhibitors
Clinical Experience with Everolimus (Certican): Optimizing Dose and Tolerability
Clinical Experience with Everolimus (Certican) in Elderly Recipients: The “Old-for-Old” Concept
Clinical Experience with Everolimus (Certican) in Young Renal Transplant Recipients
Clinical Experience with Everolimus (Certican): A Summary